Skip to content
Clinical Trials – home
Clinica Universidad De Navarra
Sponsor

Clinica Universidad De Navarra

Spain Avenue Pio XII 36, 31008 Pamplona, Spain

About the sponsor

Clinical research at Clinica Universidad De Navarra includes pancreatic adenocarcinoma with liver metastases and locally advanced colon cancer, with interest in combined systemic and surgical management. The sponsor also supports studies in high grade malignant brain neoplasm and recurrent or refractory high grade brain tumors, reflecting a focus on difficult-to-treat solid tumors.

  • Metastatic pancreatic adenocarcinoma
  • Locally advanced colon cancer
  • High grade brain tumors

These oncology trials include multimodal treatment strategies spanning chemotherapy, surgery, and local tumor-directed approaches.

About Specializations

Clinica Universidad De Navarra runs clinical trials in conditions such as Brain neoplasm malignant, Acute lymphocytic leukaemia, Pancreatic carcinoma metastatic, Colon cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

10 clinical trials

Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Sponsor:Clinica Universidad De Navarra
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Transpocart19
  • Sponsor:Clinica Universidad De Navarra
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Clinica Universidad De Navarra
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Clinica Universidad De Navarra
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Sodium Chloride Solution 0.9%
  • Sponsor:Clinica Universidad De Navarra
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Clinica Universidad De Navarra
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Octreotide
  • Sponsor:Clinica Universidad De Navarra
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Izaflortaucipir (18F)
  • Sponsor:Clinica Universidad De Navarra

Actinic keratosis

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tirbanibulin
  • Sponsor:Clinica Universidad De Navarra

Schizophrenia

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Tolcapone
  • Sponsor:Clinica Universidad De Navarra

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).